Citation Impact
Citing Papers
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization
2020
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
2024 StandoutNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope
2021
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
2018
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
2018
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis
2019
Lipid nanoparticles for mRNA delivery
2021 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Modified mRNA Vaccines Protect against Zika Virus Infection
2017
Zika Virus Pathogenesis and Tissue Tropism
2017
A new coronavirus associated with human respiratory disease in China
2020 StandoutNature
COVID-19: A promising cure for the global panic
2020 Standout
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Zika virus: from an obscurity to a priority
2018
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Pregnancy and infection: using disease pathogenesis to inform vaccine strategy
2018
Zika virus vaccines: immune response, current status, and future challenges
2018
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
2020
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
2016
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Development of vaccines against Zika virus
2018
A Biologically-validated HCV E1E2 Heterodimer Structural Model
2017
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Generation of a reporter yellow fever virus for high throughput antiviral assays
2020 StandoutNobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
2022
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
pH Dependence of Zika Membrane Fusion Kinetics Reveals an Off-Pathway State
2018
De Novo Generation and Characterization of New Zika Virus Isolate Using Sequence Data from a Microcephaly Case
2017
Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
2019
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
2020 StandoutNobel
Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity
2019
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
2019
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease
2017
Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
2019 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease
2019
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Works of Trevor Barnes being referenced
Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles
2018
HCV E2 core structures and mAbs: something is still missing
2014
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis
2017
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
2016 Nature
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes
2019
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
2015
Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy
2014